You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma

  • Technology appraisal guidance
  • Reference number: TA268
  • Published:  12 December 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Melanoma (stage III or IV) - ipilimumab: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)

Melanoma (stage III or IV) - ipilimumab: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD) Melanoma (stage III or IV) - ipilimumab: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)
02 November 2012
(352.9 Kb 42 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 31 October 2012

Back to top